How many drugs treat Ovulation induction?

Drug Landscape tracks 6 marketed treatments for Ovulation induction (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/ovulation-induction.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Ovulation induction — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ovulation induction (disease) competitive landscape: 6 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

6 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Ovulation induction, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Org 36286	CORIFOLLITROPIN ALFA	Merck Sharp & Dohme Limited		Follicle-stimulating hormone receptor	2010-01-01
Ganirelix Acetate	GANIRELIX	Organon Usa Organon	Gonadotropin Releasing Hormone Receptor Antagonist	Gonadotropin-releasing hormone receptor	1999-01-01
Urofollitropin	FOLLITROPIN	Serono	Gonadotropin [EPC]	Follicle-stimulating hormone receptor	1986-01-01
Clomid	clomifene	Sanofi	Estrogen Agonist/Antagonist	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	1967-01-01
Elonva	Elonva	University Medical Centre Ljubljana		Follicle-stimulating hormone receptor
Clomid	Clomid	rana alaaeldin aly ibrahim nasr		3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase, 5-hydroxytryptamine receptor 6, Adenosine receptor A3

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Merck Sharp & Dohme Limited · 1 drug in Ovulation induction
Organon Usa Organon · 1 drug in Ovulation induction
Sanofi · 1 drug in Ovulation induction
Serono · 1 drug in Ovulation induction
University Medical Centre Ljubljana · 1 drug in Ovulation induction
rana alaaeldin aly ibrahim nasr · 1 drug in Ovulation induction

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Ovulation induction:

Cite this brief

Drug Landscape (2026). Ovulation induction — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/ovulation-induction. Accessed 2026-06-10.

Ovulation induction full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing